Ladenburg Thalmann Financial Services’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,188
| Closed | -$94K | – | 5487 |
|
|
2018
Q2 | $94K | Hold |
1,188
| – | – | ﹤0.01% | 2790 |
|
|
2018
Q1 | $94K | Buy |
1,188
+133
| +13% | +$9.81K | ﹤0.01% | 2790 |
|
|
2017
Q4 | $72K | Buy |
1,055
+250
| +31% | +$13K | ﹤0.01% | 2978 |
|
|
2017
Q3 | $32K | Buy |
805
+350
| +77% | +$13.5K | ﹤0.01% | 3408 |
|
|
2017
Q2 | $18K | Buy |
455
+150
| +49% | +$5.49K | ﹤0.01% | 3694 |
|
|
2017
Q1 | $10K | Buy |
+305
| New | +$7.61K | ﹤0.01% | 4016 |
|
|
2016
Q4 | – | Sell |
-310
| Closed | -$7K | – | 5033 |
|
|
2016
Q3 | $7K | Hold |
310
| – | – | ﹤0.01% | 4042 |
|
|
2016
Q2 | $6K | Sell |
310
-35
| -10% | -$633 | ﹤0.01% | 4080 |
|
|
2016
Q1 | $6K | Buy |
345
+310
| +886% | +$5K | ﹤0.01% | 4030 |
|
|
2015
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 4602 |
|
|
2015
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 4520 |
|
|
2015
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 4583 |
|
|
2015
Q1 | $2K | Hold |
35
| – | – | ﹤0.01% | 4343 |
|
|
2014
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 4284 |
|
|
2014
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 3856 |
|
|
2014
Q2 | $1K | Buy |
+35
| New | +$887 | ﹤0.01% | 3825 |
|
Ladenburg Thalmann Financial Services's FMI Position: Q3 2018 in Review
Ladenburg Thalmann Financial Services sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 1,188 shares — an estimated $94K sold.
Ladenburg Thalmann Financial Services first reported a position in FMI in Q2 2014 and held it in 16 quarters. The position peaked at $94K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Ladenburg Thalmann Financial Services reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 1,188 Foundation Medicine, Inc. shares in Q3 2018, an estimated $94K.
- Ladenburg Thalmann Financial Services first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 16 quarters.
- Ladenburg Thalmann Financial Services's Foundation Medicine, Inc. position peaked at $94K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.